RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial

Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial

Add to Collection
RCTs HU Häring, L Merker, E Seewaldt-Becker… - Diabetes …, 2014 - Am Diabetes Assoc

Chapter : Section2, Section9
Journal Year : 2014
Cited by : 422

… of patients with confirmed hypoglycemic AEs was low, and no hypoglycemic events required assistance. Hypoglycemia represents a safety risk for patients with type 2 diabetes, with …..... Read More

Keywords : ['randomize doubleblind placebocontrolle trial', 'type diabetes', 'patient', 'metformin', 'empagliflozin', 'addon']
PubMed Link : https://diabetesjournals.org/care/article-abstract/37/6/1650/29568
Google Scholar Link : https://scholar.google.com/scholar?cites=15757435327687528453&as_sdt=4000005&sciodt=0,18&hl=en&num=20